drugset / Trial / NCT05933486
Efficacy and Safety of Tongluo-Kaibi Tablet in Patients With Fibromyalgia Syndrome
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is a multi-center, randomized, double-blinded, controlled trial with two parallel arms. The aim of the study is to evaluate efficacy and safety of Tongluo-Kaibi tablets in patients with Fibromyalgia Syndrome.
Timeline
- Start
- 2023-09
- Primary completion
- 2023-11
- Completion
- 2024-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pregabalin | Small molecule | 150 mg | — |
| Subject | Tongluo-Kaibi Tablet | Unknown | 0.93 g | — |